Skip to content
10-K

Annual Report

LogicBio Therapeutics, Inc.

0001564590-22-008771

← back to feed
Filed
Mar 4, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Feb 25, 2022 32.96M sh
Capex FY 2021 · Dec 31, 2021 $840K
Capex FY 2021 · Dec 31, 2020 $476K
Operating Cash Flow FY 2021 · Dec 31, 2021 −$19M
Operating Cash Flow FY 2021 · Dec 31, 2020 −$28.93M
Long Term Debt FY 2021 · Dec 31, 2021 $5.01M
Long Term Debt FY 2021 · Dec 31, 2020 $8.11M
Short Term Debt FY 2021 · Dec 31, 2021 $3.3M
Short Term Debt FY 2021 · Dec 31, 2020 $1.91M
Cash And Equivalents FY 2021 · Dec 31, 2021 $53.48M
Cash And Equivalents FY 2021 · Dec 31, 2020 $70.08M
Stockholders Equity FY 2021 · Dec 31, 2021 $30.73M
Stockholders Equity FY 2021 · Dec 31, 2020 $61.43M
Current Liabilities FY 2021 · Dec 31, 2021 $19.58M
Current Liabilities FY 2021 · Dec 31, 2020 $6.15M
Total Liabilities FY 2021 · Dec 31, 2021 $32.04M
Total Liabilities FY 2021 · Dec 31, 2020 $19.21M
Current Assets FY 2021 · Dec 31, 2021 $55.67M
Current Assets FY 2021 · Dec 31, 2020 $72.54M
Total Assets FY 2021 · Dec 31, 2021 $62.77M
Total Assets FY 2021 · Dec 31, 2020 $80.64M
Sga Expense FY 2021 · Dec 31, 2021 $16.23M
Sga Expense FY 2021 · Dec 31, 2020 $12.21M
Rd Expense FY 2021 · Dec 31, 2021 $28.17M
Rd Expense FY 2021 · Dec 31, 2020 $22.75M
Net Income FY 2021 · Dec 31, 2021 −$40.03M
Net Income FY 2021 · Dec 31, 2020 −$32.62M
Operating Income FY 2021 · Dec 31, 2021 −$38.99M
Operating Income FY 2021 · Dec 31, 2020 −$31.51M
Revenue FY 2021 · Dec 31, 2021 $5.41M
Revenue FY 2021 · Dec 31, 2020 $3.45M
Stock Issued FY 2021 · Oct 31, 2018 1.05M sh